Christopher Heaphy
PhD
Associate Professor of Pathology
👥Biography 个人简介
Christopher Heaphy established the definitive link between ATRX/DAXX mutations and ALT activation in cancer. His seminal study of pancreatic neuroendocrine tumors and gliomas demonstrated that loss of ATRX or DAXX chromatin remodeling proteins is the primary genetic mechanism triggering ALT pathway activation. He developed ALT detection assays now used in clinical pathology to guide treatment decisions.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Christopher Heaphy 的研究动态
Follow Christopher Heaphy's research updates
留下邮箱，当我们发布与 Christopher Heaphy（Boston University School of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment